Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...

As per their name, entry/attachment inhibitors work by blocking the virus's ability to attach to or enter healthy host cells. They do so by binding to different receptors on the surface of the host ...

Veterans Affairs (VA) Health Administration guidelines on COX-2 inhibitors allow their use as an alternative to traditional NSAIDs for pain management in patients taking warfarin; however ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a variety of heart-related conditions including high blood pressure, coronary ...

DOACs are as effective and safe as warfarin—sometimes more so—and are far more straightforward to take. Dr. Mitchell said, "For example, apixaban (a DOAC) has a lower risk of significant ...

Vitamin K-inhibiting anticoagulants, especially warfarin, have become standard ... significant benefit with warfarin and other vitamin K inhibitors. The generalizability of these randomized ...

In the matched cohort, DOAC use (versus warfarin) was associated with a lower rate of ischemic ... antiplatelet agents, proton‐pump inhibitors, and statins), and measures of health care use (eg, ...

Adenosine deaminase inhibitors blocking inosine and hypoxanthine production abolished the inhibition of L-arginine on osteoclastogenesis in vitro and in vivo. Altered arginine levels were also found ...

Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P. R. China State Key Laboratory of Chemical Biology, ...

4F-PCC indicates 4 factor prothrombin complex concentrate; ANNEXA-4, Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors; NOAC, novel oral anticoagulants; RE-VERSE AD, ...